This invention provides substituted bicyclic pyrimidine compounds of the following formula:
or a pharmaceutically acceptable salt thereof, wherein R is selected from the group consisting of H and a straight or branched chain alkyl group having from 1 to 10 carbon atoms, wherein the alkyl group is partially or completely saturated, each having tubulin and multiple receptor inhibition properties. Methods of treating a patient diagnosed with cancer are disclosed comprising administering to the patient a therapeutically effective amount of the substituted bicyclic pyrimidine compounds, or a pharmaceutically acceptable salt thereof.
本发明提供了下式的取代双环
嘧啶化合物:
或其药学上可接受的盐,其中 R 选自由 H 和具有 1 至 10 个碳原子的直链或支链烷基组成的组,其中烷基部分或完全饱和,每种化合物都具有抑制小管蛋白和多种受体的特性。本发明公开了治疗诊断为癌症的患者的方法,包括向患者施用治疗有效量的取代双环
嘧啶化合物或其药学上可接受的盐。